Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Exogenus Therapeutics in Cantanhede, Portugal, seeks a Scientist with hands-on bioassay experience to join our R&D team. You will develop and run cell-based bioassays, design experiments and document results with traceable records.
This role offers flexibility for suitable non-laboratory tasks and remote work for such activities, with a focus on cross-disciplinary collaboration and high-quality documentation. English is mandatory; Portuguese is highly recommended.
Cantanhede, Portugal | Laboratory-based role with flexibility for suitable non-laboratory tasks
Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee osteoarthritis. We are also exploring applications in cisplatin-induced hearing loss and other regenerative medicine indications. We combine scientific rigour, collaboration and responsible innovation to advance new therapies for patients.
We are looking for a Scientist with hands‑on experience in cell-based bioassays to join our R&D team in Cantanhede. You will develop and run bioassays, contribute to experimental design and data interpretation, and support the introduction of robust workflows for research and quality‑control applications. This role is well suited to someone who enjoys practical laboratory work, careful documentation and collaboration across scientific disciplines.
At Exogenus Therapeutics, we are not just a team, we are a family that values innovation, collaboration, and the drive to revolutionize healthcare. Our culture thrives on teamwork, mutual respect, and a shared passion for making a significant impact in the EV field. We believe that our employees are our greatest asset, and we are committed to supporting their professional and personal growth. Exogenus Therapeutics is committed to creating equal opportunities and an inclusive recruitment process and workplace. We welcome applications from people with different backgrounds, experiences and perspectives.
Applications will be reviewed on a rolling basis until 30 October 2026